Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Bofill-De Ros

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Molecular Therapy. Nucleic Acids|August 17, 2023
Toward learning the rules that predict siRNA efficacyXavier Bofill-De Ros
Molecular Therapy. Nucleic Acids|August 22, 2022
Restoration of microRNA metabolism trigger robust antitumor responsesXavier Bofill-De Ros
Molecular Therapy. Nucleic Acids|June 6, 2022
RNA targeting using CasRx can prevent aminoglycoside-induced hearing lossXavier Bofill-De Ros
Molecular Therapy. Nucleic Acids|September 16, 2024
Metabolism of tRNAs and rRNAs shape immunoactive signatures in chronic obstructive pulmonary disease and pulmonary infectionsZhenyi Hong, Xavier Bofill-De Ros
Methods (San Diego, Calif.)|April 17, 2016
Guidelines for the optimal design of miRNA-based shRNAsXavier Bofill-De Ros, Shuo Gu
RNA Biology|November 30, 2023
Recent progress in miRNA biogenesis and decayXavier Bofill-De Ros, Ulf Andersson Vang Ørom
Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|April 7, 2019
IsomiRs: Expanding the miRNA repression toolbox beyond the seedXavier Bofill-De Ros, Acong Yang, Shuo Gu
Oncotarget|February 26, 2015
Late-phase miRNA-controlled oncolytic adenovirus for selective killing of cancer cellsXavier Bofill-De Ros, Eneko Villanueva, Cristina Fillat
Methods and Protocols|April 25, 2025
Analysis of Processing, Post-Maturation, and By-Products of shRNA in Gene and Cell Therapy ApplicationsZhenyi Hong, Nikola Tesic, Xavier Bofill-De Ros
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 5, 2014
miR-148a- and miR-216a-regulated oncolytic adenoviruses targeting pancreatic tumors attenuate tissue damage without perturbation of miRNA activityXavier Bofill-De Ros, Meritxell Gironella, Cristina Fillat
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Molecular Therapy. Nucleic Acids|August 17, 2023
Toward learning the rules that predict siRNA efficacyXavier Bofill-De Ros
Molecular Therapy. Nucleic Acids|August 22, 2022
Restoration of microRNA metabolism trigger robust antitumor responsesXavier Bofill-De Ros
Molecular Therapy. Nucleic Acids|June 6, 2022
RNA targeting using CasRx can prevent aminoglycoside-induced hearing lossXavier Bofill-De Ros
Molecular Therapy. Nucleic Acids|September 16, 2024
Metabolism of tRNAs and rRNAs shape immunoactive signatures in chronic obstructive pulmonary disease and pulmonary infectionsZhenyi Hong, Xavier Bofill-De Ros
Methods (San Diego, Calif.)|April 17, 2016
Guidelines for the optimal design of miRNA-based shRNAsXavier Bofill-De Ros, Shuo Gu
RNA Biology|November 30, 2023
Recent progress in miRNA biogenesis and decayXavier Bofill-De Ros, Ulf Andersson Vang Ørom
Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|April 7, 2019
IsomiRs: Expanding the miRNA repression toolbox beyond the seedXavier Bofill-De Ros, Acong Yang, Shuo Gu
Oncotarget|February 26, 2015
Late-phase miRNA-controlled oncolytic adenovirus for selective killing of cancer cellsXavier Bofill-De Ros, Eneko Villanueva, Cristina Fillat
Methods and Protocols|April 25, 2025
Analysis of Processing, Post-Maturation, and By-Products of shRNA in Gene and Cell Therapy ApplicationsZhenyi Hong, Nikola Tesic, Xavier Bofill-De Ros
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 5, 2014
miR-148a- and miR-216a-regulated oncolytic adenoviruses targeting pancreatic tumors attenuate tissue damage without perturbation of miRNA activityXavier Bofill-De Ros, Meritxell Gironella, Cristina Fillat
Pageof 3